Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70480 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Solenn Klutsch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Marseille, (AP-HM), Centre Hospitalo-Universitaire Timone, service d'Hépatologie, Marseille, France. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B Antibodies, Hepatitis B Core Antigens, Hepatitis B virus. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was supported by the French Government under the "Investments for the Future" program managed by the National Agency for Research (ANR), Méditerrané…, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Reactivations of hepatitis B virus (HBV) infection in severely immunocompromised patients with serological profiles of past hepatitis B are non‐exceptional and potentially severe or fatal events. The preventive and pre‐emptive detection of this serological status is compromised in the absence of antibodies to hepatitis B core antigen (anti‐HBc), observed in a very small number of cases of HBV infection. Here, we describe the case of a patient with a serological profile indicating a HBV vaccination although the patient did not report previous vaccination, following lymphoma and chemotherapy including rituximab. This patient presented HBV reactivation with appearance of hepatitis B surface antigen (HBsAg) but without appearance of anti‐HBc, suggesting the absence of detectable anti‐HBc in this patient at the stage of past infection. Next‐generation sequencing provided the complete HBV genome, showing the presence of a mutation in HBsAg associated with immune escape but without the detection of mutations in the core gene previously described as significantly associated with the absence of anti‐HBc. Nonetheless, W28* pre‐core mutation was found, which was reported to enhance replication capacity in case of weak immune responses and suspected to promote HBV reactivation in association with immune escape mutations. Overall, this case highlights that negativity of anti‐HBc cannot definitely rule out past HBV infection and the risk of HBV reactivation in immunocompromised patients in the context of treatment of hemopathies, and that it is difficult to assess such a risk and to prevent or monitor HBV reactivation in patients with past HBV infection but no detectable anti‐HBc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assistance Publique-Hôpitaux de Marseille, (AP-HM), Centre Hospitalo-Universitaire Timone, service d'Hépatologie, Marseille, France.
- IHU Méditerranée Infection, Marseille, France.
- Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
- Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille University, Marseille, France.
- Pôle de Médecine Interne et Maladies Infectieuses, Hôpital Européen, Marseille, France.
- Laboratoire Alphabio, Marseille, France.
ORCID-Profile: Philippe Colson
Förderung
- This study was supported by the French Government under the "Investments for the Future" program managed by the National Agency for Research (ANR), Méditerrané…
- Agence Nationale de la Recherche
Zitieren
APA
Klutsch, S., Boschi, C., Motte, A., Halfon, P., Borentain, P., Gerolami, R., & Colson, P. (2025). Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient. Journal of Medical Virology. https://doi.org/10.1002/jmv.70480
Vancouver
Klutsch S, Boschi C, Motte A, Halfon P, Borentain P, Gerolami R, et al. Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient. Journal of Medical Virology. 2025. doi:10.1002/jmv.70480
BibTeX
@article{Klutsch2025,
author = {Klutsch, Solenn and Boschi, Céline and Motte, Anne and Halfon, Philippe and Borentain, Patrick and Gerolami, René and Colson, Philippe},
title = {Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70480}
}
EUVIMED